Advertisement
Screener

Zyla Life Sciences Paid-in-Kind Interest

Zyla Life Sciences Paid-in-Kind Interest

Zyla Life Sciences reported Paid-in-Kind Interest of $4.02 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:PaidInKindInterest · last filed 2016-11-08

  • Zyla Life Sciences paid-in-kind interest for the quarter ending 2016-09-30 was $1.43M, a 25.31% increase year-over-year.
  • Zyla Life Sciences paid-in-kind interest for the quarter ending 2016-06-30 was $430.00K, a 69.33% decline year-over-year.
  • Zyla Life Sciences paid-in-kind interest for the quarter ending 2016-03-31 was $2.16M, a 1589.84% increase year-over-year.
  • Zyla Life Sciences paid-in-kind interest for the quarter ending 2015-12-31 was $1.29M.
  • Zyla Life Sciences paid-in-kind interest for fiscal 2015 was $3.96M, a 43.37% decline from fiscal 2014.
  • Zyla Life Sciences paid-in-kind interest for fiscal 2014 was $6.99M, a 17.13% decline from fiscal 2013.
  • Zyla Life Sciences paid-in-kind interest for fiscal 2013 was $8.43M.
Period endPaid-in-Kind Interest 3 monthPaid-in-Kind Interest 6 monthPaid-in-Kind Interest 6 month as first filedPaid-in-Kind Interest 9 monthPaid-in-Kind Interest 9 month as first filedPaid-in-Kind Interest 12 month
2016-09-30$1.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$1.86M
derived: sum of 2 quarters · filed 2016-11-08
$4.02M
10-Q · filed 2016-11-08
$5.31M
derived: sum of 4 quarters · filed 2016-11-08
2016-06-30$430.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$2.59M
10-Q · filed 2016-08-05
$3.88M
derived: sum of 3 quarters · filed 2016-08-05
$5.02M
derived: sum of 4 quarters · filed 2016-11-08
2016-03-31$2.16M
10-Q · filed 2016-05-10
$3.45M
derived: sum of 2 quarters · filed 2016-05-10
$4.59M
derived: sum of 3 quarters · filed 2016-11-08
$5.99M
derived: sum of 4 quarters · filed 2016-11-08
2015-12-31$1.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$2.43M
derived: sum of 2 quarters · filed 2016-11-08
$3.83M
derived: sum of 3 quarters · filed 2016-11-08
$3.96M
10-K · filed 2016-03-11
2015-09-30$1.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$2.54M
derived: sum of 2 quarters · filed 2016-11-08
$2.67M
10-Q · filed 2016-11-08
$184.00K
10-Q · filed 2015-11-06
$2.67M
derived: sum of 4 quarters · filed 2016-11-08
2015-06-30$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$1.53M
10-Q · filed 2016-08-05
$119.00K
10-Q · filed 2015-08-07
$1.53M
derived: sum of 3 quarters · filed 2016-08-05
$1.53M
derived: sum of 4 quarters · filed 2016-08-05
2015-03-31$128.00K
10-Q · filed 2016-05-10
$128.00K
derived: sum of 2 quarters · filed 2016-05-10
$128.00K
derived: sum of 3 quarters · filed 2016-05-10
$128.00K
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$0.00
derived: sum of 2 quarters · filed 2016-03-11
$0.00
derived: sum of 3 quarters · filed 2016-03-11
$6.99M
10-K · filed 2016-03-11
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$0.00
derived: sum of 2 quarters · filed 2015-11-06
$6.99M
10-Q · filed 2015-11-06
$11.15M
derived: sum of 4 quarters · filed 2016-03-11
2014-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$6.99M
10-Q · filed 2015-08-07
$11.15M
derived: sum of 3 quarters · filed 2016-03-11
$14.09M
derived: sum of 4 quarters · filed 2016-03-11
2014-03-31$6.99M
10-Q · filed 2014-06-11
$11.15M
derived: sum of 2 quarters · filed 2016-03-11
$14.09M
derived: sum of 3 quarters · filed 2016-03-11
2013-12-31$4.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
$7.10M
derived: sum of 2 quarters · filed 2016-03-11
$8.43M
10-K · filed 2016-03-11
2013-09-30$2.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14
$4.26M
10-Q · filed 2014-11-14
2013-06-30$1.33M
10-Q · filed 2014-08-14